Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jan;7(1):29-31.
doi: 10.1111/jdi.12380. Epub 2015 Jun 30.

Renoprotective effects of incretin-based drugs: A novel pleiotropic effect of dipeptidyl peptidase-4 inhibitor

Ryo Kodera  1 , Kenichi Shikata  1
Affiliations
Review

Renoprotective effects of incretin-based drugs: A novel pleiotropic effect of dipeptidyl peptidase-4 inhibitor

Ryo Kodera et al. J Diabetes Investig. 2016 Jan.

Abstract

Renoprotective effects of incretin‐based drug.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Different mechanisms of incretin‐based drugs. DPP‐4, dipeptidyl peptidase‐4; GIP, glucose‐dependent insulinotropic polypeptide; GLP‐1, glucagon‐like peptide 1; SDF‐1α, stromal derived factor‐1α.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Kanasaki K, Shi S, Kanasaki M, et al Linagliptin‐mediated DPP‐4 inhibition ameliorates kidney fibrosis in streptozotocin‐induced diabetic mice by inhibiting endothelial‐to‐mesenchymal transition in a therapeutic regimen. Diabetes 2014; 63: 2120–2131. - PubMed
    1. Chaykovska L, von Websky K, Rahnenfuhrer J, et al Effects of DPP‐4 inhibitors on the heart in a rat model of uremic cardiomyopathy. PLoS ONE 2011; 6: e27861. - PMC - PubMed
    1. Kaji K, Yoshiji H, Ikenaka Y, et al Dipeptidyl peptidase‐4 inhibitor attenuates hepatic fibrosis via suppression of activated hepatic stellate cell in rats. J Gastroenterol 2014; 49: 481–491. - PubMed
    1. Kodera R, Shikata K, Takatsuka T, et al Dipeptidyl peptidase‐4 inhibitor ameliorates early renal injury through its anti‐inflammatory action in a rat model of type 1 diabetes. Biochem Biophys Res Commun 2014; 443: 828–833. - PubMed
    1. Ta NN, Li Y, Schuyler CA, et al DPP‐4 (CD26) inhibitor alogliptin inhibits TLR4‐mediated ERK activation and ERK‐dependent MMP‐1 expression by U937 histiocytes. Atherosclerosis 2010; 213: 429–435. - PubMed

MeSH terms